Holen Sie sich die Stockscreener-App
13.88
4.08%
-0.59
Handel nachbörslich:
13.88
Schlusskurs vom Vortag:
$14.47
Offen:
$14.5
24-Stunden-Volumen:
465.36K
Relative Volume:
1.32
Marktkapitalisierung:
$699.01M
Einnahmen:
$62.02M
Nettoeinkommen (Verlust:
$-45.65M
KGV:
-15.09
EPS:
-0.92
Netto-Cashflow:
$-9.60M
1W Leistung:
-2.94%
1M Leistung:
+3.20%
6M Leistung:
+46.57%
1J Leistung:
+69.06%
1-Tages-Spanne:
$13.80
$14.54
1-Wochen-Bereich:
$13.80
$14.54
52-Wochen-Spanne:
$7.88
$14.55
Theravance Biopharma Inc Stock (TBPH) Company Profile
Firmenname
Theravance Biopharma Inc
Sektor
Branche
Telefon
650-808-6000
Adresse
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
Vergleichen Sie TBPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TBPH
Theravance Biopharma Inc
|
13.88 | 728.73M | 62.02M | -45.65M | -9.60M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-12 | Eingeleitet | B. Riley Securities | Buy |
| 2024-08-06 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-04-12 | Eingeleitet | BTIG Research | Buy |
| 2024-01-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-05-23 | Eingeleitet | SVB Leerink | Outperform |
| 2021-11-05 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2021-08-25 | Herabstufung | Morgan Stanley | Overweight → Underweight |
| 2021-08-24 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-10-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-07 | Eingeleitet | JP Morgan | Overweight |
| 2020-06-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-05-13 | Eingeleitet | Cowen | Outperform |
| 2020-01-08 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-06 | Hochstufung | Robert W. Baird | Underperform → Neutral |
| 2019-10-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-29 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-06-16 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-05-11 | Bestätigt | Needham | Buy |
| 2016-12-21 | Eingeleitet | Needham | Buy |
| 2016-11-03 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-10-12 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2016-08-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2016-06-20 | Eingeleitet | Guggenheim | Buy |
| 2016-06-20 | Bestätigt | Leerink Partners | Outperform |
| 2016-05-12 | Eingeleitet | Leerink Partners | Outperform |
| 2016-05-05 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2015-02-03 | Hochstufung | Robert W. Baird | Underperform → Neutral |
Alle ansehen
Theravance Biopharma Inc Aktie (TBPH) Neueste Nachrichten
Acadian Asset Management LLC Purchases 174,451 Shares of Theravance Biopharma, Inc. $TBPH - MarketBeat
Theravance Biopharma (NASDAQ:TBPH) Reaches New 52-Week HighShould You Buy? - MarketBeat
Published on: 2025-09-19 20:47:30 - newser.com
Combining machine learning predictions for Theravance Biopharma Inc.Portfolio Growth Summary & Consistent Return Investment Signals - newser.com
Candlestick signals on Theravance Biopharma Inc. stock todayWeekly Investment Summary & Expert Approved Trade Ideas - newser.com
Analyzing net buyer seller activity in Theravance Biopharma Inc.Portfolio Risk Summary & Expert Curated Trade Setup Alerts - newser.com
What data driven models say about Theravance Biopharma Inc.’s futureJuly 2025 Snapshot & Safe Capital Investment Plans - newser.com
Is it too late to sell Theravance Biopharma Inc.2025 Retail Activity & Weekly Stock Breakout Alerts - newser.com
Is Theravance Biopharma Inc. stock reversal real or fakeEarnings Trend Report & Daily Market Momentum Tracking - newser.com
Multi factor analysis applied to Theravance Biopharma Inc.July 2025 Trade Ideas & Stock Timing and Entry Methods - newser.com
Published on: 2025-09-19 12:39:39 - newser.com
Institution Moves: Is Theravance Biopharma Inc. stock risky to hold nowJuly 2025 Patterns & Low Risk High Win Rate Stock Picks - khodrobank.com
Quarterly Earnings: Is Theravance Biopharma Inc attractive at current valuationJuly 2025 Fed Impact & Short-Term Trading Alerts - khodrobank.com
Has Theravance Biopharma Inc. found a price floorWeekly Trade Report & Weekly Breakout Watchlists - newser.com
Theravance Biopharma, Inc. (NASDAQ:TBPH) Sees Significant Increase in Short Interest - Defense World
Published on: 2025-09-19 02:25:08 - newser.com
Theravance Biopharma, Inc. (NASDAQ:TBPH) Short Interest Update - MarketBeat
Why is Theravance Biopharma Inc stock going down2025 Key Highlights & Free Daily Entry Point Trade Alerts - khodrobank.com
Is Theravance Biopharma Inc. stock risky to hold nowJuly 2025 Patterns & Low Risk High Win Rate Stock Picks - khodrobank.com
Momentum Shift: Can Theravance Biopharma Inc stock double in the next yearQuarterly Market Review & Fast Moving Stock Trade Plans - khodrobank.com
Theravance Biopharma (NASDAQ:TBPH) Rating Lowered to Hold at Zacks Research - MarketBeat
Jacobs Levy Equity Management Inc. Sells 276,666 Shares of Theravance Biopharma, Inc. $TBPH - MarketBeat
Theravance Biopharma (NASDAQ:TBPH) Upgraded to "Strong-Buy" at B. Riley - MarketBeat
Should you wait for a breakout in Theravance Biopharma Inc.Weekly Market Outlook & Technical Confirmation Trade Alerts - newser.com
Evaluating Theravance Biopharma Inc. with trendline analysisIndex Update & Free Technical Confirmation Trade Alerts - newser.com
Theravance Biopharma (NASDAQ:TBPH) Coverage Initiated at B. Riley - MarketBeat
Cubist Systematic Strategies LLC Takes Position in Theravance Biopharma, Inc. $TBPH - MarketBeat
Will Theravance Biopharma Inc. benefit from macro trendsTrade Risk Summary & Daily Stock Trend Watchlist - newser.com
Insider Trends: Can NTWOW stock outperform in a bear marketWeekly Gains Summary & Reliable Entry Point Alerts - خودرو بانک
Inflation Data: Is Theravance Biopharma Inc stock showing strong momentumJuly 2025 Momentum & Free Long-Term Investment Growth Plans - خودرو بانک
Applying Elliott Wave Theory to Theravance Biopharma Inc.Swing Trade & High Conviction Investment Ideas - newser.com
Can Theravance Biopharma Inc. be recession proofWeekly Market Outlook & Daily Profit Maximizing Tips - khodrobank.com
Gap Down: Can Theravance Biopharma Inc sustain its profitabilityInflation Watch & Reliable Intraday Trade Alerts - خودرو بانک
Quarterly Trades: Can Theravance Biopharma Inc stock double in the next yearWeekly Volume Report & Expert Curated Trade Setup Alerts - khodrobank.com
Analyzing drawdowns of Theravance Biopharma Inc. with statistical toolsEarnings Growth Summary & Long-Term Safe Return Strategies - newser.com
Volatility clustering patterns for Theravance Biopharma Inc.Price Action & Real-Time Volume Trigger Notifications - newser.com
Bull Bear: How volatile is Theravance Biopharma Inc. stockJuly 2025 Volume & AI Driven Stock Price Forecasts - خودرو بانک
Tick level data insight on Theravance Biopharma Inc. volatility2025 Retail Activity & Free Real-Time Market Sentiment Alerts - newser.com
Can swing trading help recover from Theravance Biopharma Inc. lossesPortfolio Growth Summary & Long-Term Growth Portfolio Plans - newser.com
Retail Trends: Whats the outlook for Theravance Biopharma Incs sector2025 Market Sentiment & Smart Allocation Stock Tips - khodrobank.com
Ranking Theravance Biopharma Inc. among high performing stocks via toolsLong Setup & Detailed Earnings Play Alerts - newser.com
Can Theravance Biopharma Inc sustain its profitability2025 Institutional Moves & Low Risk High Reward Ideas - khodrobank.com
Bull Run: Is Theravance Biopharma Inc affected by consumer sentimentDollar Strength & Verified High Yield Trade Plans - khodrobank.com
Aug Technicals: Can TCBIO generate free cash flow2025 Sector Review & Technical Entry and Exit Tips - خودرو بانک
Analysts Set Theravance Biopharma, Inc. (NASDAQ:TBPH) Price Target at $23.00 - Defense World
Theravance Biopharma (NASDAQ:TBPH) Shares Up 4.6%Should You Buy? - MarketBeat
Finanzdaten der Theravance Biopharma Inc-Aktie (TBPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.43%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):